Evidence map›Paper›PMID 35645290›Full record

ArticleJournal of xenobiotics2022

Genotoxicity of Three Micro/Nanocelluloses with Different Physicochemical Characteristics in MG-63 and V79 Cells.

Célia Ventura, Catarina Marques, João Cadete, Madalena Vilar, Jorge F S Pedrosa, Fátima Pinto, Susete Nogueira Fernandes, Rafaela Raupp da Rosa, Maria Helena Godinho, Paulo J T Ferreira and 2 more

Abstract read
In one paragraph

Article in Journal of xenobiotics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Célia VenturaDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.
Catarina MarquesDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.
João CadeteDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.
Madalena VilarDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.
Jorge F S PedrosaCIEPQPF, Department of Chemical Engineering, University of Coimbra, Pólo II, Rua Silvo Lima, 3030-790 Coimbra, Portugal.ORCID 0000-0002-6900-1592
Fátima PintoDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.
Susete Nogueira FernandesCENIMAT/I3N, Department of Materials Science, NOVA School of Science and Technology (FCT NOVA), NOVA University Lisbon, Campus da Caparica, 2829-516 Caparica, Portugal.ORCID 0000-0002-7871-6717
Rafaela Raupp da RosaCENIMAT/I3N, Department of Materials Science, NOVA School of Science and Technology (FCT NOVA), NOVA University Lisbon, Campus da Caparica, 2829-516 Caparica, Portugal.
Maria Helena GodinhoCENIMAT/I3N, Department of Materials Science, NOVA School of Science and Technology (FCT NOVA), NOVA University Lisbon, Campus da Caparica, 2829-516 Caparica, Portugal.ORCID 0000-0002-9760-5983
Paulo J T FerreiraCIEPQPF, Department of Chemical Engineering, University of Coimbra, Pólo II, Rua Silvo Lima, 3030-790 Coimbra, Portugal.ORCID 0000-0002-4503-6811
Henriqueta LouroDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.ORCID 0000-0001-9744-7332
Maria João SilvaDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal.ORCID 0000-0002-6060-0716

Funding

European Topology Interdisciplinary Action EUTOPIA CA17139Fundação para a Ciência e Tecnologia PTDC/SAU-PUB/32587/2017, PTDC/CTM-REF/30529/2017, UIDB/50025/2020-2023, UIDP/00009/2020; UIDB/00009/2020, UIDB/00102/2020Portugal 2020 through ERDF in the frame of COMPETE Project N.º 21874
6 · The paper itself

Abstract

(1) Background: Nanocellulose is an innovative engineered nanomaterial with an enormous potential for use in a wide array of industrial and biomedical applications and with fast growing economic value. The expanding production of nanocellulose is leading to an increased human exposure, raising concerns about their potential health effects. This study was aimed at assessing the potential toxic and genotoxic effects of different nanocelluloses in two mammalian cell lines; (2) Methods: Two micro/nanocelluloses, produced with a TEMPO oxidation pre-treatment (CNFs) and an enzymatic pre-treatment (CMFs), and cellulose nanocrystals (CNCs) were tested in osteoblastic-like human cells (MG-63) and Chinese hamster lung fibroblasts (V79) using the MTT and clonogenic assays to analyse cytotoxicity, and the micronucleus assay to test genotoxicity; (3) Results: cytotoxicity was observed by the clonogenic assay in V79 cells, particularly for CNCs, but not by the MTT assay; CNF induced micronuclei in both cell lines and nucleoplasmic bridges in MG-63 cells; CMF and CNC induced micronuclei and nucleoplasmic bridges in MG-63 cells, but not in V79 cells; (4) Conclusions: All nanocelluloses revealed cytotoxicity and genotoxicity, although at different concentrations, that may be related to their physicochemical differences and availability for cell uptake, and to differences in the DNA damage response of the cell model.

Indexed as

cytotoxicitygenotoxicitymicronucleus assaynanocrystalline cellulosenanofibrillated cellulosenanotoxicology

Identifiers

PMID35645290
PMCPMC9149940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.